KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Assets (2016 - 2026)

Boston Scientific's Assets history spans 18 years, with the latest figure at $44.4 billion for Q1 2026.

  • On a quarterly basis, Assets rose 10.49% to $44.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $44.4 billion, a 10.49% increase, with the full-year FY2025 number at $43.7 billion, up 10.86% from a year prior.
  • Assets hit $44.4 billion in Q1 2026 for Boston Scientific, up from $43.7 billion in the prior quarter.
  • Over the last five years, Assets for BSX hit a ceiling of $44.4 billion in Q1 2026 and a floor of $31.9 billion in Q3 2022.
  • Historically, Assets has averaged $37.0 billion across 5 years, with a median of $36.7 billion in 2024.
  • Biggest five-year swings in Assets: grew 0.22% in 2022 and later rose 12.16% in 2025.
  • Tracing BSX's Assets over 5 years: stood at $32.5 billion in 2022, then grew by 8.21% to $35.1 billion in 2023, then grew by 12.12% to $39.4 billion in 2024, then grew by 10.86% to $43.7 billion in 2025, then grew by 1.55% to $44.4 billion in 2026.
  • Business Quant data shows Assets for BSX at $44.4 billion in Q1 2026, $43.7 billion in Q4 2025, and $42.7 billion in Q3 2025.